StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Post by johnny007on Jan 03, 2018 11:19am

187 Views

Post# 27270787

TA Pullback: D 20ma 16c or D 50ma 13c sup

.. as expected the pullback, good.

Now let's guess which moving average will be used for the bounce
WHEN the NEWS happens. Surely a timing issue.
But maybe Milost is also waiting for the pullback to not have their costs being exploded?

Tick tock .. until its going - assuming all the expectations are well funded and being realized.
(Not a scam)

Bullboard Posts

How one company is disrupting PoC testing